- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06417294
Effects of a 3D-Printed Port-A Catheter Model Training Course
Effects of a 3D-Printed Port-A Catheter Model Training Course for Patient Discharge Instruction
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Cancer patients often require long-term administration of chemotherapy drugs, nutritional supplementation, and blood transfusions. During these treatments, an implantable central venous access (port-a catheter) is often utilized to avoid the inconvenience of repeated needle insertions for treatment and to minimize the risk of medication leakage. Port-A catheters are considered a safer clinical measure. However, poor care and maintenance of the catheter can lead to complications such as infection, catheter damage, and leakage, which can even result in death. The study aims to assess the impact of patient discharge education on their knowledge and satisfaction regarding catheter care.
Methods: This study focuses on patient education and evaluating its effectiveness. It employs a prospective randomized controlled trial with a cross-sectional design and parallel groups. The participants are divided into the 3D model group (experimental group) and the conventional education group (control group). A total of 120 subjects from the hematology-oncology ward are included in the study. The participants are randomly assigned to either the experimental group (60 participants) or the control group (60 participants) based on the month of admission, following a cluster randomization approach.
Effect: The investigator anticipate that the use of a 3D-printed upper body Port-A catheter model will yield better results in patient discharge education.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ke-Yun Chao, PhD
- Phone Number: +886905301879
- Email: C00152@mail.fjuh.fju.edu.tw
Study Locations
-
-
-
New Taipei City, Taiwan, 24352
- Recruiting
- Fu Jen Catholic University Hospital, Fu Jen Catholic University
-
Contact:
- Ke-Yun Chao, PhD
- Phone Number: +886-905-301-879
- Email: ck_qq@hotmail.com
-
Principal Investigator:
- Ke-Yun Chao, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Admitted to the hematology and oncology ward of Fu Jen Catholic University Hospital
- Have Chinese communication skills
Exclusion Criteria:
- Refused to participate in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: traditional education group
Received a regular education
|
Regular education
|
|
Experimental: 3D model group
Received a explanation combined with 3D printed model
|
explanation combined with 3D printed health education model
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient education effectiveness questionnaire
Time Frame: immediately after the intervention
|
higher scores mean a better outcome
|
immediately after the intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ke-Yun Chao, PhD, Fu Jen Catholic University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- FJUH112278
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
Clinical Trials on traditional education
-
Karabuk UniversityActive, not recruitingHealth Education | Passive Smoking | Tobacco Smoke Pollution | Peer Group GuidanceTurkey (Türkiye)
-
Duke UniversityCompletedFallopian Tube Cancer | Peritoneal Cancer | Ovarian Cancer, EpithelialUnited States
-
Sakarya UniversityNot yet recruiting
-
Keller Army Community HospitalCompletedChronic Low Back Pain | Post-traumatic StressUnited States
-
Akdeniz UniversityPamukkale UniversityCompletedMusculoskeletal PainTurkey
-
Ömercan AksoyCompletedPostpartum Hemorrhage | Simulation Based Medical Education | Obstetric CareTurkey (Türkiye)
-
Gazi UniversityNot yet recruitingNursing Education | Gamification | Ostomy - Ileostomy or Colostomy | Stoma Care Education in Nursing Students
-
Chulabhorn HospitalCompletedSurgery | Educational Problems
-
Universiti Putra MalaysiaRecruitingPerformance | Physical FitnessChina
-
Aalborg UniversityNordsimRecruitingUltrasound TrainingDenmark